Barclays Issues Pessimistic Forecast for Sotera Health (NASDAQ:SHC) Stock Price
Sotera Health (NASDAQ:SHC – Get Free Report) had its price objective reduced by investment analysts at Barclays from $18.00 to $17.00 in a research report issued on Tuesday,Benzinga reports. The firm currently has an “overweight” rating on the stock. Barclays‘s price objective would suggest a potential upside of 24.72% from the company’s previous close. A […]
Sotera Health (NASDAQ:SHC – Get Free Report) had its price objective reduced by investment analysts at Barclays from $18.00 to $17.00 in a research report issued on Tuesday,Benzinga reports. The firm currently has an “overweight” rating on the stock. Barclays‘s price objective would suggest a potential upside of 24.72% from the company’s previous close. A […]
